New York, New York, United States The main office of represented VC is situated in the New York. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the The Keffi Group, startups are often financed by Prospect Venture Partners. The meaningful sponsors for the fund in investment in the same round are Prospect Venture Partners, Pinnacle Ventures, Apothecary Capital.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Cogentus Pharmaceuticals Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund.
The top activity for fund was in 2007. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Agility Ventures | Haryana, Haryana, India |
| Allied Architects | Chiyoda, Japan |
| APEC | Hsinchu, Taiwan, Taiwan Province |
| GGR Capital | Beijing, Beijing, China |
| Harvest Investments | Chicago, Illinois, United States |
| Janus Capital Group | Colorado, Denver, United States |
| Lemnos VC | California, San Francisco, United States |
| LITTLEROCK | Düsseldorf, Germany, Nordrhein-Westfalen |
| Mahindra Rise | India, Maharashtra, Mumbai |
| NITTO KOGYO | Chiyoda, Japan |
| Product Trust Investments | - |
| Symbiotics Group | Geneva, Geneve, Switzerland |
| Tracker Capital Management | New York, New York, United States |
| transcosmos inc | Japan, Kanagawa Prefecture, Kawasaki |
| Triangle Venture Alliance | - |
| Vanenburg Group | Gelderland, Putten, The Netherlands |
| Vaxa Capital Partners | Greenville, South Carolina, United States |
| Verily | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Mitra Chem | $40M | 16 Aug 2023 | Palo Alto, California, United States | ||
Cogentus Pharmaceuticals | $62M | 21 Dec 2007 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Mitra Chem | $40M | 16 Aug 2023 | Palo Alto, California, United States | ||
Cogentus Pharmaceuticals | $62M | 21 Dec 2007 | California, United States |
